Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |